Parkin induces apoptotic cell death in TNF-α-treated cervical cancer cells
![]() |
Lee, Kyung-Hong
(Department of Biomedical Laboratory Science, College of Health Sciences, Yonsei University)
Lee, Min-Ho (Department of Biomedical Laboratory Science, College of Health Sciences, Yonsei University) Kang, Yeo-Wool (Department of Biomedical Laboratory Science, College of Health Sciences, Yonsei University) Rhee, Ki-Jong (Department of Biomedical Laboratory Science, College of Health Sciences, Yonsei University) Kim, Tae-Ue (Department of Biomedical Laboratory Science, College of Health Sciences, Yonsei University) Kim, Yoon-Suk (Department of Biomedical Laboratory Science, College of Health Sciences, Yonsei University) |
1 | Sah, N. K., Khan, Z., Khan, G. J. and Bisen, P. S. (2006) Structural, functional and therapeutic biology of survivin. Cancer Lett. 244, 164-171. DOI ScienceOn |
2 | Tamm, I., Wang, Y., Sausville, E., Scudiero, D. A., Vigna, N., Oltersdorf, T. and Reed, J. C. (1998) IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res. 58, 5315-5320. |
3 | Chen, G. and Goeddel, D. V. (2002) TNF-R1 signaling: a beautiful pathway. Science 296, 1634-1635. DOI ScienceOn |
4 | Friedrichs, B., Siegel, S., Andersen, M. H., Schmitz, N. and Zeis, M. (2006) Survivin-derived peptide epitopes and their role for induction of antitumor immunity in hematological malignancies. Leuk. Lymphoma. 47, 978-985. DOI ScienceOn |
5 | Machida, Y., Chiba, T., Takayanagi, A., Tanaka, Y., Asanuma, M., Ogawa, N., Koyama, A., Iwatsubo, T., Ito, S., Jansen, P. H., Shimizu, N., Tanaka, K., Mizuno, Y. and Hattori, N. (2005) Common anti-apoptotic roles of parkin and alpha-synuclein in human dopaminergic cells. Biochem. Biophys. Res. Commun. 332, 233-240. DOI ScienceOn |
6 | Staropoli, J. F. (2008) Tumorigenesis and neurodegeneration: two sides of the same coin? Bioessays 30, 719-727. DOI ScienceOn |
7 | Springer, W. and Kahle, P. J. (2011) Regulation of PINK1-Parkin-mediated mitophagy. Autophagy 7, 266-278. DOI |
8 | Kim, Y. S., Patel, S. and Lee, S. J. (2006) Lack of direct role of parkin in the steady-state level and aggregation of alpha-synuclein and the clearance of pre-formed aggregates. Exp. Neurol. 197, 538-541. DOI ScienceOn |
9 | Shin, D. H., Park, K. W., Wu, L. C. and Hong, J. W. (2011) ZAS3 promotes TNFalpha-induced apoptosis by blocking NFkappaB-activated expression of the anti-apoptotic genes TRAF1 and TRAF2. BMB Rep. 44, 267-272. DOI ScienceOn |
10 | Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E. and Forman, D. (2011) Global cancer statistics. CA. Cancer J. Clin. 61, 69-90. DOI |
11 | Mehdi, S. J., Alam, M. S., Batra, S. and Rizvi, M. M. (2011) Allelic loss of 6q25-27, the PARKIN tumor suppressor gene locus, in cervical carcinoma. Med. Oncol. 28, 1520-1526. DOI ScienceOn |
12 | Franco, D. L., Nojek, I. M., Molinero, L., Coso, O. A. and Costas, M. A. (2002) Osmotic stress sensitizes naturally resistant cells to TNF-alpha-induced apoptosis. Cell Death Differ. 9, 1090-1098. DOI ScienceOn |
13 | Tewari, M., Quan, L. T., O'Rourke, K., Desnoyers, S., Zeng, Z., Beidler, D. R., Poirier, G. G., Salvesen, G. S. and Dixit, V. M. (1995) Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly (ADP-ribose) polymerase. Cell 81, 801-809. DOI ScienceOn |
14 | Nunez, G., Benedict, M. A., Hu, Y. and Inohara, N. (1998) Caspases: the proteases of the apoptotic pathway. Oncogene 17, 3237-3245. DOI |
15 | Fernandes-Alnemri, T., Armstrong, R. C., Krebs, J., Srinivasula, S. M., Wang, L., Bullrich, F., Fritz, L. C., Trapani, J. A., Tomaselli, K. J., Litwack, G. and Alnemri, E. S. (1996) In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD- like domains. Proc. Natl. Acad. Sci. U.S.A 93, 7464-7469. DOI |
16 | Park, S. J., Shin, J. H., Kang, H., Hwang, J. J. and Cho, D. H. (2011) Niclosamide induces mitochondria fragmentation and promotes both apoptotic and autophagic cell death. BMB Rep. 44, 517-522. DOI ScienceOn |
17 | Igney, F. H. and Krammer, P. H. (2002) Death and anti-death: tumour resistance to apoptosis. Nat. Rev. Cancer 2, 277-288. DOI ScienceOn |
18 | Picchio, M. C., Martin, E. S., Cesari, R., Calin, G. A., Yendamuri, S., Kuroki, T., Pentimalli, F., Sarti, M., Yoder, K., Kaiser, L. R., Fishel, R. and Croce, C. M. (2004) Alterations of the tumor suppressor gene Parkin in non-small cell lung cancer. Clin. Cancer Res. 10, 2720-2724. DOI ScienceOn |
19 | Wang, F., Denison, S., Lai, J. P., Philips, L. A., Montoya, D., Kock, N., Schule, B., Klein, C., Shridhar, V., Roberts, L. R. and Smith, D. I. (2004) Parkin gene alterations in hepatocellular carcinoma. Genes. Chromosomes. Cancer 40, 85-96. DOI ScienceOn |
20 | Agirre, X., Roman-Gomez, J., Vazquez, I., Jimenez-Velasco, A., Garate, L., Montiel-Duarte, C., Artieda, P., Cordeu, L., Lahortiga, I., Calasanz, M. J., Heiniger, A., Torres, A., Minna, J. D. and Prosper, F. (2006) Abnormal methylation of the common PARK2 and PACRG promoter is associated with downregulation of gene expression in acute lymphoblastic leukemia and chronic myeloid leukemia. Int. J. Cancer 118, 1945-1953. DOI ScienceOn |
21 | Wang, H., Liu, B., Zhang, C., Peng, G., Liu, M., Li, D., Gu, F., Chen, Q., Dong, J. T., Fu, L. and Zhou, J. (2009) Parkin regulates paclitaxel sensitivity in breast cancer via a microtubule-dependent mechanism. J. Pathol. 218, 76-85. DOI ScienceOn |
22 | Coussens, L. M. and Werb, Z. (2002) Inflammation and cancer. Nature 420, 860-867. DOI ScienceOn |
23 | Wang, C. Y., Mayo, M. W., Korneluk, R. G., Goeddel, D. V. and Baldwin, A. S., Jr. (1998) NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281, 1680-1683. DOI ScienceOn |
24 | Beutler, B., Greenwald, D., Hulmes, J. D., Chang, M., Pan, Y. C., Mathison, J., Ulevitch, R. and Cerami, A. (1985) Identity of tumour necrosis factor and the macrophage-secreted factor cachectin. Nature 316, 552-554. DOI ScienceOn |
25 | Aggarwal, B. B. (2003) Signalling pathways of the TNF superfamily: a double-edged sword. Nat. Rev. Immunol. 3, 745-756. DOI ScienceOn |
26 | Denison, S. R., Wang, F., Becker, N. A., Schule, B., Kock, N., Phillips, L. A., Klein, C. and Smith, D. I. (2003) Alterations in the common fragile site gene Parkin in ovarian and other cancers. Oncogene 22, 8370-8378. DOI ScienceOn |
27 | Oates, A. J., Schumaker, L. M., Jenkins, S. B., Pearce, A. A., DaCosta, S. A., Arun, B. and Ellis, M. J. (1998) The mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R), a putative breast tumor suppressor gene. Breast. Cancer Res. Treat. 47, 269-281. DOI ScienceOn |
28 | Shridhar, V., Staub, J., Huntley, B., Cliby, W., Jenkins, R., Pass, H. I., Hartmann, L. and Smith, D. I. (1999) A novel region of deletion on chromosome 6q23.3 spanning less than 500 Kb in high grade invasive epithelial ovarian cancer. Oncogene 18, 3913-3918. DOI |
29 | Denison, S. R., Callahan, G., Becker, N. A., Phillips, L. A. and Smith, D. I. (2003) Characterization of FRA6E and its potential role in autosomal recessive juvenile parkinsonism and ovarian cancer. Genes Chromosomes Cancer 38, 40-52. DOI ScienceOn |
30 | Poulogiannis, G., McIntyre, R. E., Dimitriadi, M., Apps, J. R., Wilson, C. H., Ichimura, K., Luo, F., Cantley, L. C., Wyllie, A. H., Adams, D. J. and Arends, M. J. (2010) PARK2 deletions occur frequently in sporadic colorectal cancer and accelerate adenoma development in Apc mutant mice. Proc. Natl. Acad. Sci. U.S.A. 107, 15145-15150. DOI ScienceOn |
31 | Tay, S. P., Yeo, C. W., Chai, C., Chua, P. J., Tan, H. M., Ang, A. X., Yip, D. L., Sung, J. X., Tan, P. H., Bay, B. H., Wong, S. H., Tang, C., Tan, J. M. and Lim, K. L. (2010) Parkin enhances the expression of cyclin-dependent kinase 6 and negatively regulates the proliferation of breast cancer cells. J. Biol. Chem. 285, 29231-29238. DOI ScienceOn |
32 | Kong, F. M., Anscher, M. S., Washington, M. K., Killian, J. K. and Jirtle, R. L. (2000) M6P/IGF2R is mutated in squamous cell carcinoma of the lung. Oncogene 19, 1572-1578. DOI |
33 | Veeriah, S., Taylor, B. S., Meng, S., Fang, F., Yilmaz, E., Vivanco, I., Janakiraman, M., Schultz, N., Hanrahan, A. J., Pao, W., Ladanyi, M., Sander, C., Heguy, A., Holland, E. C., Paty, P. B., Mischel, P. S., Liau, L., Cloughesy, T. F., Mellinghoff, I. K., Solit, D. B. and Chan, T. A. (2010) Somatic mutations of the Parkinson's disease-associated gene PARK2 in glioblastoma and other human malignancies. Nat. Genet. 42, 77-82. DOI ScienceOn |
34 | Shimura, H., Schlossmacher, M. G., Hattori, N., Frosch, M. P., Trockenbacher, A., Schneider, R., Mizuno, Y., Kosik, K. S. and Selkoe, D. J. (2001) Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease. Science 293, 263-269. DOI ScienceOn |
![]() |